REITHERA SRL
- Country
- 🇮🇹Italy
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.reithera.com
Study of GRAd-COV2 for the Prevention of COVID-19 in Adults
- Conditions
- Covid19
- Interventions
- Biological: GRAd-COV2Other: Placebo
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- ReiThera Srl
- Target Recruit Count
- 10300
- Registration Number
- NCT04791423
- Locations
- 🇮🇹
Fondaz.Irccs Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy
🇮🇹Ospedale S.Gerardo - Monza, Monza, Italy
🇮🇹Azienda Ospedaliera Policlinico Umberto I, Roma, Italy
Phase I Study to Assess the Safety and Immunology of a COVID-19 Vaccine With GRAd-COV2 Vaccine
- Conditions
- COVID-19
- Interventions
- Biological: GRAd-COV2
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- ReiThera Srl
- Target Recruit Count
- 98
- Registration Number
- NCT04528641
- Locations
- 🇮🇹
INMI Spallanzani, Rome, Italy
🇮🇹Centro Ricerche Cliniche, Verona, Italy
RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- Biological: PanAd3-RSV given intra-nasally (high dose)Biological: MVA-RSV given by intra-muscular injection (high dose)Biological: PanAd3-RSV given by intra-muscular injection (high dose)Biological: MVA-RSV given by intra-muscular injection (low dose)Biological: PanAd3-RSV given intranasally (low dose)Biological: PanAd3-RSV given by intra-muscular injection (low dose)
- First Posted Date
- 2013-03-06
- Last Posted Date
- 2016-04-26
- Lead Sponsor
- ReiThera Srl
- Target Recruit Count
- 72
- Registration Number
- NCT01805921
- Locations
- 🇬🇧
Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford, Oxfordshire, United Kingdom
Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients
- Conditions
- Hepatitis C
- Interventions
- Biological: Ad6NSmut, MVA-NSmut
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2013-08-29
- Lead Sponsor
- ReiThera Srl
- Target Recruit Count
- 9
- Registration Number
- NCT01701336
- Locations
- 🇮🇹
Azienda Ospedaliera Universitaria Pisana. Ospedale di Santa Chiara, Pisa, Italy
🇮🇹Azienda Ospedaliera Universitaria di Pisa. Ospedale di Cisanello, Pisa, Italy
Study of a New MVA Vaccine for Hepatitis C Virus
- Conditions
- Hepatitis C Infection
- Interventions
- Biological: MVA-NSmutBiological: AdCh3NSmutBiological: AdCh3NSmut1
- First Posted Date
- 2011-02-15
- Last Posted Date
- 2016-04-26
- Lead Sponsor
- ReiThera Srl
- Target Recruit Count
- 55
- Registration Number
- NCT01296451
- Locations
- 🇬🇧
Wycombe Hospital, High Wycombe, Buckinghamshire, High Wycombe, United Kingdom
🇬🇧John Radcliffe Hospital, Headley Way, Headington, Oxford, United Kingdom
🇬🇧Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom
Study of a Novel Therapeutic Vaccine for Hepatitis C Virus
- Conditions
- Hepatitis C
- Interventions
- Biological: AdCh3NSmutBiological: Ad6NSmut
- First Posted Date
- 2010-03-29
- Last Posted Date
- 2015-04-23
- Lead Sponsor
- ReiThera Srl
- Target Recruit Count
- 35
- Registration Number
- NCT01094873
- Locations
- 🇬🇧
Wellcome Clinical Research Facility, Queen Elizabeth's Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, West Midlands, United Kingdom
🇬🇧John Radcliffe Hospital, Headley Way, Headington, Oxford, United Kingdom
A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV)
- Conditions
- Hepatitis C
- Interventions
- Biological: Ad6NSmut; AdCh3NSmutBiological: AdCh3NSmut; Ad6NSmut
- First Posted Date
- 2010-02-18
- Last Posted Date
- 2015-04-23
- Lead Sponsor
- ReiThera Srl
- Target Recruit Count
- 41
- Registration Number
- NCT01070407
- Locations
- 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom
🇬🇧Wellcome Clinical Research Facility, Queen Elizabeth's Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, West Midlands, United Kingdom